New research in JNCCN—Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated according to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), 90% were likely to survive their cancer for their remaining life-expectancy. The study is titled “Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer.”
This article was originally published on MedicalXpress.com